- €5.69bn
- €18.18bn
- €6.59bn
- 59
- 64
- 18
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS/A | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,099 | 5,340 | 4,933 | 6,064 | 6,592 |
Cost of Revenue | |||||
Gross Profit | 2,341 | 2,255 | 1,963 | 2,232 | 2,495 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,005 | 4,344 | 4,338 | 5,258 | 5,793 |
Operating Profit | 1,094 | 996 | 595 | 806 | 799 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 817 | 879 | 350 | 361 | 224 |
Provision for Income Taxes | |||||
Net Income After Taxes | 649 | 748 | 265 | 271 | 181 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 625 | 619 | 189 | 208 | 59.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 625 | 619 | 189 | 208 | 59.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.954 | 1.01 | 1.05 | 0.49 | 0.515 |
Dividends per Share |